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Operative endoscopy has become a common therapeutic advancement in clinical practice [1, 2, 3, 4, 5] New techniques generate comparisons with established techniques. The positive aspects of these comparisons can get lost in a field of mere competition when different medical specialties are involved.
In the last 12 years, we have created in our Department of Surgery, a center for operative endoscopy, where gastroenterologists and surgeons perform operative endoscopy. We report our experience in this endoscopic section, analyzing the results of endoscopic placement of colorectal stenting, we started to use since 1999. 
COLORECTAL ENDOSCOPIC STENTING:
In a 16 year period (August 1999 -December 2016 , 167 patients with colorectal cancer had endoscopic placement of a Self Expandable Metal Stent (SEMS) for treatment of an obstructing colorectal cancer (145 patients), or for treatment of complications after colorectal resection for cancer (22 patients). They were prospectively evaluated in a data base, and they form the basis of this report SEMS PLACEMENT : Patients with complete obstruction as determined by preoperative sigmoidoscopy and CT scan, had only a low pressure water enema few hours before the procedure. In selected patients a complete bowel preparation was performed, if there was no evidence of complete obstruction. The procedure was performed under light sedation with benzodiazepine, at a dosage depending on patient body weight. A guidewire was passed through the obstruction. In the initial experience, the guidewire was passed blindly through the obstruction, under fluoroscopic and endoscopic guidance. The guidewire was directed towards the obstruction with a colonoscope which remained distally to the tumour, 5 to avoid the risk of perforation. Thanks to the suggestion of an endoscopist , a modified technique has been introduced [6, 7, 8] (Fig 1, Fig 2) . A pediatric nasogastroscope (4,8 mm in diameter) has been used to pass the obstruction. This manoeuvre makes possible to have a direct vision of the anatomy and pathology , and to pass the guidewire above the obstruction, through the nasogastroscope, under direct vision [6] . This has made the procedure much simpler, faster, and theoretically with reduced risk of perforation or bleeding. Time of exposure to radiaton (fluoroscopy) has dimished from 15 to 4 minutes.
The SEMS apparatus (Precision Stent System Microvasive, Boston Scientific Corporation, Boston, USA) is placed at the level of the obstruction, through the guidewire previously inserted, and deployed under fluoroscopic guidance, with a landing zone of 2 cm above and below the tumor. The length of the stent ranged from 9 to 12 cm. We used mainly uncovered stents: initially Ultraflex OTS stent, lately Wallflex TTS stents (Boston Scientific,
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RESULTS.
Mortality and Morbidity: There was no case of postoperative mortality or major morbidity after SEMS placement. There were no cases of bowel perforation or major bleeding.
Technical success was obtained in 95.1% of the 167 patients. In 8 patients it was not possible to pass the guidewire through the obstruction, due to sharp angulation of the obstruction. After consulting a surgeon, the procedure was not continued. Surgical colorectal resection appeared a more appropriate procedure. After consultation between surgeons and gastroenterologists, the option of surgery was considered the safest and best option. The operative option, chosen before intervention, was changed in 60 patients. In thirty five patients, initially considered candidate for stenting, surgery was considered a more appropriate choice after consulation among specialists. Twenty five patients, initially considered candidates for surgery, had endoscopic stenting after consultation among the specialists of the centre. (Fig 3) Instead, a covered self expandable metal stent was placed (B). Thanks to its radial pressure the bleeding stopped completely. Nine days later, the covered stent was removed and an uncovered stent was placed (uncovered stents dislodge less frequently than covered stents)(C). Endoscopic view.
Follow-up:
Patients were followed by the same team who was involved n stent placement. As concern stent placement for stage IV colorectal cancer, endoscopic re intervention was performed in 28% of the patients during a mean follow up of 22 months.
There were 2 cases of stent displacement, 2 cases of tumor ingrowth within the stent. The majority of the complications were related to fecal impaction. All complications were treated successfully endoscopically .
DISCUSSION.
SEMS placement has been accepted in daily clinical practice [5, 9, 10, 11, 12, 13, 14] . The role of SEMS in this setting has been source of controversies [16, 17] Randomized prospective studies comparing SEMS placement as a bridge to [22, 23, 24] All these studies showed a highly significant heterogeneity, raising the doubt that the large variability of reported results could be a consequence of a significant patient selection. [25] . Four reports analyzed the five year oncological outcome of patients who had resection after SEMS placement and after emergency surgery, and no difference was found in terms of local or distant recurrence between the two groups of patients [26, 27, 28, 29] . More recently Foo et al found contrasting results, with increased rate of distant metastases in patients who had stenting before colorectal resection [30] .
In patients with Stage IV colorectal cancer, and symptoms of acute and sub acute obstruction, stenting can represent a valid choice, especially when colorectal resection carries a significant operative risks. Short hospital stay and almost immediate resume of oral feeding can be expected after stenting.
Prospective randomized studies and review of regional data bases [31, 32] comparing stenting versus diverting colostomy have shown lower complication rate and shorter hospital stay in patients who had a stent. Diverting colostomy represents a significant problem for patients in whom general conditions slowly deteriorate. Chemotherapy can be started without any delay. In patients with
Stage IV obstructing colorectal cancer and good general conditions, surgical resection offers many theoretical advantages in comparison to stenting:
conceptual more effective action of chemotherapy [33, 34, 35] and prevention of recurrent cancer obstruction, with the possibility of a better quality of life [36] Reports [23, 37, 38, 39] . Parks et al [46] showed better results with increased experience. Retrospective studies have
shown that technical success is higher when the operator has performed more than 20 procedures [16, 47] . However, in more recent reports we found increased complication rates [48] . This fact was more evident in reports describing a larger number of patients in comparison to reports with smaller number of patients. This fact could be explained by a more aggressive use of SEMS placement in centers with larger experience, in comparison to a more selected, and prudent indication in centers at their initial experience.
Very few papers have focused the attention to a proper collaboration between specialists before and during the SEMS placement.
In our experience, there has been no case of mortality or major morbidity.
SEMS is not so simple as it could appear , and it should done by experienced In such a way, SEMS can be placed in the right position. As suggested by the European Society for Gastrointestinal Endoscopy, the stent should have a landing zone at least for 2 cm and 2 cm below the tumor [16] .
The location of the tumour is an important point to be considered. A majority of the colorectal cancers, which presents with obstruction, are located in the rectosigmoid junction . In these situations, a proper evaluation is fundamental.
If the patient does not have major clinical problems , and the colon above the obstruction is not very dilated, surgical resection with a primary anastomosis is quite a simple and straightforward procedure. In these selected cases, a low ligation of the inferior mesenteric artery is advisable. If needed, a protective proximal diverting stoma can be fashioned, to be closed easily 2 weeks later under local anesthesia. It can be difficult to place a stent in the proper position, in these relatively high locations, namely in case of complete obstruction just at the level of a sharp the curvature of the rectosigmoid junction. In the other cases (middle-lower rectum, inferior aspect of the rectosigmoid junction), stent placement is much easier and it is preferred to a more demanding operation. Colorectal stenting, as suggested by the European Society for Gastrointestinal Endoscopy should be avoided in the right and transverse colon. It is very difficult to place the stent in the right position in these anatomic locations, and the risk for complications is high.
There is a high possibility of complications related to the stent itself, during the follow up.
Considering patients with stage IV obstructing colorectal cancer, in an average follow up of 21 months, 28% of the patients required a new endoscopy in our experience. Even if these complications (fecal impaction, stent migration, tumour ingrowth within the stent) can be treated with success endoscopically, a very careful follow up is required. In this context, it is imperative to consider the possibility and willingness by the patient and her/his family for a close follow up, in choosing the best therapeutic option.
CONCLUSIONS
. The therapeutic options in patients with acute or subacute malignant colorectal obstruction, including endoscopic placement of a stent, should be based on a careful analysis of the different risk factors. In this scenario, a close collaboration among specialists in selecting the most appropriate operative procedure , is essential and brings to better results. 
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